InvestSMART

Creso Pharma Limited (ASX: CPH) - Announcements

- Current share price for CPH : $0.009

ASX company news and announcements for Creso Pharma Limited (CPH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Creso Pharma Limited (CPH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Creso Pharma Limited (CPH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Creso Pharma Limited (CPH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Proposed issue of Securities - CPH 20 Apr 2020 3:17PM $0.079 $0.009 fallen by 88.61%
- Proposed issue of Securities - CPH 20 Apr 2020 3:14PM $0.079 $0.009 fallen by 88.61%
- Funding Update 20 Apr 2020 9:15AM $0.082 $0.009 fallen by 89.02%
- Israeli JV Update 20 Apr 2020 9:13AM $0.082 $0.009 fallen by 89.02%
- Notice of General Meeting/Proxy Form 15 Apr 2020 8:14AM $0.088 $0.009 fallen by 89.77%
- L1 Capital Collateral Purchase Notice & Top-Up Notice 14 Apr 2020 10:42AM $0.090 $0.009 fallen by 90%
- Pause in Trading 14 Apr 2020 10:05AM $0.090 $0.009 fallen by 90%
- Binding LOI to Expand Distribution into Pakistan 14 Apr 2020 8:19AM $0.093 $0.009 fallen by 90.32%
- ASX Listing Rule 3.13.1 Notice Regarding AGM 8 Apr 2020 8:28AM $0.066 $0.009 fallen by 86.36%
- Appendix 3G 7 Apr 2020 7:28PM $0.066 $0.009 fallen by 86.36%
- Creso Completes AUD 200,000 Order of anibidiol to Virbac 7 Apr 2020 9:43AM $0.061 $0.009 fallen by 85.25%
- Creso Pharma Outlines Response to COVID-19 2 Apr 2020 11:07AM $0.059 $0.009 fallen by 84.75%
- Pause in Trading 2 Apr 2020 9:44AM $0.059 $0.009 fallen by 84.75%
- Mernova Receives C$775k Order for First Shipment to Israel 1 Apr 2020 9:45AM $0.059 $0.009 fallen by 84.75%
- First Shipment of cannaQIX to South Africa For Launch in Q2 26 Mar 2020 8:28AM $0.054 $0.009 fallen by 83.33%
- Creso Pharma to Launch CBD Hemp Tea 24 Mar 2020 10:08AM $0.046 $0.009 fallen by 80.43%
- Ceasing to be a substantial holder - Correction 12 Mar 2020 4:07PM $0.066 $0.009 fallen by 86.36%
- Ceasing to be a substantial holder 11 Mar 2020 5:16PM $0.073 $0.009 fallen by 87.67%
- Creso Strengthens Mernova Senior Management Team 11 Mar 2020 10:33AM $0.070 $0.009 fallen by 87.14%
- Trading Halt 10 Mar 2020 10:05AM $0.070 $0.009 fallen by 87.14%
- Pause in Trading 10 Mar 2020 9:54AM $0.070 $0.009 fallen by 87.14%
- Becoming a substantial holder 6 Mar 2020 4:57PM $0.078 $0.009 fallen by 88.46%
- Creso Signs Agreement to Market its Products in Scandinavia 3 Mar 2020 9:20AM $0.080 $0.009 fallen by 88.75%
- Termination of Israeli Joint Venture 2 Mar 2020 5:45PM $0.080 $0.009 fallen by 88.75%
- Appendix 4G & Corporate Governance Statement 28 Feb 2020 5:48PM $0.086 $0.009 fallen by 89.53%

526 - 550 of 891 results

Page 22 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.